In order to continually provide quality, accessible, and affordable treatment of sexually transmitted diseases (STI) in the country, the Philippine Department of Health (DOH) has engaged PRIMEX to review its policies, standards, and guidelines on STI treatment.
New reports on the ‘sporadic observations on clinical resistance of common STI-causing microorganisms’ has triggered the need to update the guidelines which were last updated in 2003. The DOH needs to gather pieces of evidence on resistance of common STI-causing agents to be able to modify current treatment regimes.
Funded by DOH through the National Center for Disease Prevention and Control (NCDPC), the research project specifically aims to
- determine the current practices of STI service providers in the diagnosis and treatment of common STI in the country;
- review the current treatment recommendations of common STI-causing microorganisms through a conduct of population-specific clinic-epidemiologic study and desk review of related studies; and
- provide DOH with recommendations on the current STI treatment regimen.
The Consultant Team is composed of Dr. Florante P. Magboo, Principal Investigator/Team Leader; Dr. Carlos L. Calica, Co-Investigator; Dr. Ofelia P. Saniel, Ph.D., Biostatistician; and Ms. Andy P. Lim, Project Manager. Overall supervision of the Team’s activities, including final review and editing of the reports for submission to DOH, is provided by Ms. Elvira Ablaza, PRIMEX President and CEO, as Project Director.
PRIMEX has submitted the Inception Report to DOH in September 2012 indicating the consultants’ work plan, milestones, and deliverables, as agreed during contract negotiations and at the meeting with the DOH NASPCP-NCPDC, consultants’ understanding of the scope of work, description of the approach and methodology and work plan to be adopted in Project implementation. The project is expected to conclude in December 2012.